Table 1.
Weekly Percentage of Decrease in Encounters and Intravitreal Injections in the 3 Retina Practices During the Initial 8 Weeks of COVID-19 Pandemic
| Encounters | Encounters | Encounters | Injections | Injections | Injections | |
|---|---|---|---|---|---|---|
| Weill Cornell | OCB | MOOR | Weill Cornell | OCB | MOOR | |
| Pre COVID-19 | 152 | 156 | 240 | 38 | 98 | 156 |
| Week 1: 3/16 | 36 (76%)* | 84 (52%) | 204 (15%) | 30 (21%) | 34 (65%) | 100 (35%) |
| Week 2: 3/23 | 19 (87%) | 59 (66%) | 112 (53%) | 9 (76%) | 25 (74%) | 84 (46%) |
| Week 3: 3/30 | 0 (100%) | 61 (65%) | 160 (33%) | 0 (100%) | 35 (64%) | 111 (28%) |
| Week 4: 4/6 | 15 (90%) | 43 (75%) | 135 (43%) | 13 (65%) | 23 (76%) | 103 (33%) |
| Week 5: 4/13 | 9 (94%) | 84 (52%) | 135 (43%) | 10 (73%) | 44 (55%) | 103 (33%) |
| Week 6: 4/20 | 19 (87%) | 60 (65%) | 134 (44%) | 17 (55%) | 26 (73%) | 113 (27%) |
| Week 7: 4/27 | 28 (81%) | 94 (46%) | 164 (31%) | 14 (36%) | 45 (54%) | 116 (25%) |
| Week 8: 5/4 | 30 (80%) | 84 (52%) | 154 (35%) | 23 (39%) | 48 (51%) | 137 (12%) |
| 8 weeks average percentage decrease | 87% | 59% | 37% | 58% | 64% | 30% |
Note: * patients present (percentage decrease).